Albert Kligman
American dermatologist and researcher
Albert Kligman[edit | edit source]
Albert Montgomery Kligman (March 17, 1916 – February 9, 2010) was an American dermatologist and researcher known for his work in the field of dermatology, particularly for the development of tretinoin (Retin-A) for the treatment of acne and photoaging.
Early Life and Education[edit | edit source]
Albert Kligman was born in Philadelphia, Pennsylvania. He attended University of Pennsylvania, where he earned his undergraduate degree. Kligman continued his education at the same institution, obtaining a Ph.D. in botany and later an M.D. from the University of Pennsylvania School of Medicine.
Career[edit | edit source]
Kligman began his career in dermatology at the University of Pennsylvania, where he conducted research on skin diseases and treatments. His work led to significant advancements in the understanding and treatment of various dermatological conditions.
Development of Tretinoin[edit | edit source]
Kligman is best known for his development of tretinoin, a derivative of vitamin A that became widely used in the treatment of acne and skin aging. Tretinoin was initially developed as a treatment for acne, but Kligman discovered its efficacy in reducing wrinkles and improving skin texture, leading to its use in anti-aging products.
Controversies[edit | edit source]
Kligman's career was not without controversy. He conducted research on inmates at Holmesburg Prison in Philadelphia, which later raised ethical concerns regarding informed consent and the treatment of human subjects in medical research. These studies were part of a broader pattern of medical experimentation on vulnerable populations during the mid-20th century.
Legacy[edit | edit source]
Despite the controversies, Kligman's contributions to dermatology have had a lasting impact. His work on tretinoin has helped millions of people manage acne and improve skin health. Kligman published numerous papers and was a respected figure in dermatological research.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
